• Interaction Score: 5.8

    Interaction Types & Directionality:
    ligand
    antibody (inhibitory)

    Interaction Info:
    Notes EP-CAM/CD3 Bispecific antibody construct (BITE)
    Trial Name catumaxomab,Removab
    Novel drug target Novel Target

    PMIDs:
    20347527


  • Interaction Score: 3.09

    Interaction Types & Directionality:
    agonist (activating)
    antibody (inhibitory)

    Interaction Info:
    Trial Name catumaxomab,Removab
    Novel drug target Established target

    PMIDs:
    20347527


    Sources:
    TdgClinicalTrial

  • Interaction Score: 2.21

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name catumaxomab,Removab
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • Interaction Score: 1.19

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Established target
    Trial Name catumaxomab,Removab

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class antibody
    FDA Approval not approved

    Publications:

    • Version: 12-May-2016

    Alternate Names:
    CATUMAXOMAB Primary Drug Name
    CATUMAXOMAB Drug Generic Name
    REMOVAB Drug Trade Name

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: